Qiaodan Liu
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: June 16, 2025
Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial.
Journal: Nature communications
Published: October 15, 2024
Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma.
Journal: Molecular carcinogenesis
Published: August 20, 2024
Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: May 20, 2024
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases.
Journal: Translational cancer research
Published: July 27, 2023
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Journal: Translational oncology
Published: July 06, 2023
Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.
Journal: Medicine
Published: January 10, 2023
Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma.
Journal: Translational cancer research
Published: November 06, 2022
Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 09, 2022
The valuable role of dynamic 18F FDG PET/CT-derived kinetic parameter Ki in patients with nasopharyngeal carcinoma prior to radiotherapy: A prospective study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 17, 2022
Encouraging efficacy of a comprehensive therapy consisting of sintilimab, bevacizumab biosimilar IBI305, hypo-fractionated intensity-modulated radiotherapy, and oxaliplatin for a maxillary metastasis from hepatocellular carcinoma: A case report and literature review.
Journal: Frontiers in oncology
Published: May 11, 2022
Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis.
Journal: Frontiers in oncology
Published: January 21, 2022
Last Updated: 09/26/2026